Detalhe da pesquisa
1.
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial.
Infect Dis Ther
; 10(4): 2333-2351, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34363189
2.
An open label trial of anakinra to prevent respiratory failure in COVID-19.
Elife
; 102021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682678
3.
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Nat Med
; 27(10): 1752-1760, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480127
4.
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Nat Med
; 27(10): 1850, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625750